Get the Stockscreener App
167.95
0.48%
0.81
After Hours:
168.49
0.54
+0.32%
Overview
News
Price History
Option Chain
Financials
Why BDX Down?
Discussions
Forecast
Stock Split
Dividend History
Becton Dickinson Co stock is traded at $167.95, with a volume of 4.23M.
It is up +0.48% in the last 24 hours and down -16.37% over the past month.
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.
See More
Previous Close:
$167.14
Open:
$167.14
24h Volume:
4.23M
Relative Volume:
1.69
Market Cap:
$48.59B
Revenue:
$20.87B
Net Income/Loss:
$1.50B
P/E Ratio:
32.05
EPS:
5.24
Net Cash Flow:
$2.59B
1W Performance:
-0.94%
1M Performance:
-16.37%
6M Performance:
-27.50%
1Y Performance:
-28.10%
1-Day Range:
$166.13
$170.49
1-Week Range:
$163.33
$171.26
52-Week Range:
$163.33
$251.99
Becton Dickinson Co Stock (BDX) Company Profile
Name
Becton Dickinson Co
Sector
Industry
Phone
(201) 847-6800
Address
ONE BECTON DR, FRANKLIN LAKES
Compare BDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
167.95 | 48.59B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ISRG
Intuitive Surgical Inc
|
538.16 | 185.37B | 8.71B | 2.48B | 1.75B | 6.82 |
|
ALC
Alcon Inc
|
95.88 | 47.57B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
243.09 | 35.70B | 5.02B | 1.31B | 1.56B | 8.91 |
|
COO
The Cooper Companies, Inc.
|
82.92 | 16.51B | 3.90B | 392.30M | 288.10M | 1.95 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-02-25 | Downgrade | Goldman | Buy → Neutral |
| May-02-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-02-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-25 | Downgrade | BofA Securities | Buy → Neutral |
| May-01-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-01-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-01-24 | Upgrade | Citigroup | Neutral → Buy |
| May-30-24 | Initiated | Goldman | Buy |
| Jul-24-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| May-05-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-12-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-03-23 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-12-22 | Upgrade | Citigroup | Sell → Neutral |
| Jul-11-22 | Downgrade | Citigroup | Neutral → Sell |
| Jun-24-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-18-22 | Resumed | Raymond James | Mkt Perform |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Dec-08-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-06-21 | Downgrade | JP Morgan | Overweight → Neutral |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Dec-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-15-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-09-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Jun-01-20 | Resumed | Goldman | Buy |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-07-20 | Downgrade | Cowen | Outperform → Market Perform |
| Feb-07-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-07-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| Feb-06-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jan-08-20 | Downgrade | Barclays | Overweight → Equal Weight |
| May-13-19 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-07-18 | Initiated | Deutsche Bank | Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Jun-21-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-10-18 | Upgrade | Citigroup | Neutral → Buy |
| Jan-19-18 | Resumed | BofA/Merrill | Buy |
| Jan-05-18 | Upgrade | Citigroup | Sell → Neutral |
| Jan-05-18 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Dec-29-17 | Reiterated | Deutsche Bank | Buy |
View All
Becton Dickinson Co Stock (BDX) Latest News
Tissue Diagnostics Market to Reach $12.4 Billion by 2029, Growing at 7.0% CAGR - GlobeNewswire Inc.
Judge declares mistrial in punitive damages phase in Walker v. BD - The Covington News
Jim Cramer on Becton, Dickinson and Company (BDX): “A Shocking Miss for This Once-Reliable Med Tech Giant” - Insider Monkey
Becton Dickinson (NYSE:BDX) Sees 18% Price Dip Over Last Week - Yahoo Finance
Becton Dickinson (BDX) Price Target Lowered by Morgan Stanley | BDX Stock News - GuruFocus
Investors Can Still File Late Claims for Becton, Dickinson & Co $85M Settlement Payouts - TradingView
Morgan Stanley Adjusts Price Target on Becton, Dickinson and Company to $196 From $280, Maintains Overweight Rating - marketscreener.com
Covington resident wins $20 million in case against Becton Dickinson - The Covington News
Becton, Dickinson, and Company (BDX): Among the Best Falling Stocks to Buy According to Analysts - Insider Monkey
Piper Sandler Downgrades Becton, Dickinson and (WBAG:BDX) - Nasdaq
Becton, Dickinson and Company (NYSE:BDX) Q2 2025 Earnings Call Transcript - Insider Monkey
Piper Sandler Downgrades Becton, Dickinson and (XTRA:BOX) - Nasdaq
Becton Dickinson downgraded to Neutral from Buy at Goldman Sachs - MSN
Becton Dickinson Vitals Drop: Analysts 'Have Been Wrong' On This Med Tech Stock For Years - Benzinga
Jefferies cuts Becton Dickinson target to $255, maintains Buy By Investing.com - Investing.com Nigeria
Raymond James cuts Becton Dickinson stock rating to Market Perform By Investing.com - Investing.com Nigeria
Becton, Dickinson Shares Drop After Multiple Analyst Downgrades - marketscreener.com
Becton Dickinson (BDX) Faces Downgrades Amid Growth Concerns - GuruFocus
Goldman Sachs cuts Becton Dickinson stock rating to neutral By Investing.com - Investing.com Nigeria
Becton Dickinson downgraded to Neutral from Overweight at Piper Sandler - TipRanks
Becton Dickinson (BDX) Sees Downgrade and Price Target Cut by Piper Sandler | BDX Stock News - GuruFocus
Becton Dickinson (BDX) Rating Maintained by Stifel, Price Target Lowered | BDX Stock News - GuruFocus
Wall Street analysts downgrade Becton Dickinson & Co. as ’confidence eroded’ - Investing.com
Medical Equipment Makers Stryker, Becton Eye Price Hikes to Offset Tariffs - Bloomberg
Becton Dickinson (BDX) Faces Downgrade Amid Growth and Tariff Co - GuruFocus
Jefferies cuts Becton Dickinson target to $255, maintains Buy - Investing.com
Raymond James cuts Becton Dickinson stock rating to Market Perform - Investing.com
Becton Dickinson (BDX) Downgraded Due to Execution Concerns | BD - GuruFocus
Becton Dickinson (BDX) Downgraded Due to Execution Concerns | BDX Stock News - GuruFocus
Becton Dickinson (BDX) Receives Downgrade as Growth Forecasts Lo - GuruFocus
Becton Dickinson (BDX) Receives Downgrade as Growth Forecasts Lowered | BDX Stock News - GuruFocus
Becton Dickinson & Co (BDX) Q2 2025 Earnings Call Highlights: St - GuruFocus
Piper Sandler cuts Becton Dickinson stock rating to neutral By Investing.com - Investing.com Nigeria
Piper Sandler cuts Becton Dickinson stock rating to neutral - Investing.com
Becton Dickinson & Co (BDX) Q2 2025 Earnings Call Highlights: Strong EPS Growth Amid ... - Yahoo Finance
Becton, Dickinson and Company (BDX) Earnings Date and Reports 2025 - MarketBeat
Becton, Dickinson Reports Q2 2025 Earnings Growth - TipRanks
Becton Dickinson (BDX) Downgraded to Market Perform by William B - GuruFocus
Becton Dickinson: Fiscal Q2 Earnings Snapshot - CT Insider
Becton Dickinson (BDX) Price Target Cut Amid Disappointing FY25 Outlook | BDX Stock News - GuruFocus
Stifel cuts Becton Dickinson target to $224, maintains buy By Investing.com - Investing.com Nigeria
Becton Dickinson (BDX) Faces Downgrades After Revised Earnings F - GuruFocus
Becton Dickinson (BDX) Downgraded by BofA Following Missed Growt - GuruFocus
Becton Dickinson (BDX) Unveils Strategic Investments Amid Q2 Rev - GuruFocus
Medical device maker Becton Dickinson cuts 2025 profit forecast on potential tariff hit - MSN
Stifel cuts Becton Dickinson target to $224, maintains buy - Investing.com
BofA downgrades Becton Dickinson to Neutral on ‘inconsistent execution’ - TipRanks
BECTON DICKINSON & CO SEC 10-Q Report - TradingView
Becton Dickinson (BDX) Faces Price Target Cut Following Challenging Quarter | BDX Stock News - GuruFocus
BofA cuts Becton Dickinson stock rating, slashes price target By Investing.com - Investing.com Nigeria
Becton Dickinson (BDX) Downgraded by Wells Fargo Following Guida - GuruFocus
Becton Dickinson Co Stock (BDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.23%
2.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):